Are Cancer Drug Trials at Risk of Overstating Benefits?

Trial data from new cancer treatments may be imparting an overly optimistic portrait of surviving the disease to patients. As a result, two oncologists have called for changes to be made to the protocols the American FDA, or Food and Drug Administration, apply to the standards of information collected. Patient Selection One cancer expert said that the positive outcomes seen with some treatments occurred when they were administered to relatively healthy and young patients. Sometimes…

"Are Cancer Drug Trials at Risk of Overstating Benefits?"